Mediterranean diet as the ideal model for preventing non-alcoholic fatty liver disease (NAFLD)
被引量：1
摘要
The prevalence of nonalcoholic fatty liver disease(NAFLD)has dramatically increased in the 2–3 last decades and it represents the most frequent global cause of liver disease,affecting 25%to 45%of adults in most studies(1).
二级参考文献47
-
1Ramesh Kumar,Shantam Mohan.Non-alcoholic Fatty Liver Disease in Lean Subjects:Characteristics and Implications[J].Journal of Clinical and Translational Hepatology,2017,5(3):216-223. 被引量：25
-
2Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
-
3Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
-
4Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
-
5Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
-
6Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
-
7Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
-
8Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
-
9Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
-
10Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].
共引文献345
-
1钱哲,缪文兴,李林东,谢澄铖,黄桂成,马勇,王建伟.基于Txnip/NLRP3/NF-κB信号通路的芍药苷干预下半月板损伤修复的实验研究[J].中西医结合心血管病电子杂志,2019,0(35):20-22. 被引量：1
-
2陈敏灵,杨柳清,李亮,衡先培,吴韦贤,林伟.非酒精性脂肪性肝病患者肝脏脂肪含量与冠状动脉狭窄的相关性研究[J].血管与腔内血管外科杂志,2020,6(4):283-289. 被引量：4
-
3甄丽影,童玉梅.脂肪纤维化评分与非酒精性脂肪性肝病死亡相关性分析[J].社区医学杂志,2020(15):1085-1088.
-
4欧阳飞凡,戴荣继,辛念,田德振,李博,邓玉林.中医药在治疗非酒精性脂肪肝病中的研究进展[J].生命科学仪器,2023,21(2):37-47.
-
5张国辉,李芳莉.基于网络药理学探讨二陈汤治疗非酒精性脂肪肝的作用机制[J].内蒙古中医药,2022,41(12):139-141.
-
6李丹霈,余学锋.论糖尿病治疗的持续性[J].内科急危重症杂志,2020(4):269-273. 被引量：3
-
7陈思童,吕文良.吕文良论治非酒精性脂肪性肝病经验[J].辽宁中医杂志,2022,49(7):31-34. 被引量：7
-
8周殿明,钱智勇.循环miRNAs作为肝损伤的新型生物标志物的研究进展[J].环境与健康杂志,2021,39(3):275-278.
-
9李红山,奚瑛斐,何哲耘.中药组分HJJB方对油酸钠诱导的HepG2细胞脂质沉积的干预作用及机制[J].中华中医药杂志,2019,34(12):5642-5645. 被引量：1
-
10Stergios A.Polyzos,Jannis Kountouras,Antonis Goulas,Eleni Papakonstantinou,Paraskevi Papaioannidou.Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity[J].Hepatobiliary Surgery and Nutrition,2020,9(1):73-76.
同被引文献12
-
1Maureen Whitsett,Lisa B VanWagner.Physical activity as a treatment of non-alcoholic fatty liver disease:A systematic review[J].World Journal of Hepatology,2015,7(16):2041-2052. 被引量：324
-
2陶叶婷,范建高.心理应激与非酒精性脂肪性肝病[J].实用肝脏病杂志,2016,19(6):753-756. 被引量：13
-
3刘路,韩涛,周冷潇.他汀类药物在肝病防治中的应用[J].临床肝胆病杂志,2017,33(5):985-989. 被引量：3
-
4温贻芳.社会心理因素与非酒精性脂肪肝的关系[J].中国健康心理学杂志,2018,26(4):565-568. 被引量：15
-
5中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会,范建高,魏来,庄辉.非酒精性脂肪性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):947-957. 被引量：1644
-
6中华医学会内分泌学分会,高鑫.非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版)[J].临床肝胆病杂志,2018,34(10):2103-2108. 被引量：95
-
7钟燕,苏淑婷,宓余强.非酒精性脂肪性肝病治疗研究进展[J].实用肝脏病杂志,2019,22(1):145-148. 被引量：14
-
8孙超,范建高.中外非酒精性脂肪性肝病诊疗指南解读[J].中国实用内科杂志,2019,39(3):235-238. 被引量：52
-
9柳惠未,叶桦.睡眠、昼夜节律及肠道菌群与非酒精性脂肪性肝病关系的研究进展[J].现代实用医学,2019,31(4):565-568. 被引量：4
-
10喻晓,王雯婕,金嘉悦,潘洁露,张海燕,邢练军.苓桂术甘汤联合益生菌治疗非酒精性脂肪肝[J].长春中医药大学学报,2019,35(5):891-894. 被引量：31
二级引证文献7
-
1王超越,黄晓巍,王雨辰,林喆.中药治疗非酒精性脂肪性肝病研究进展[J].人参研究,2022,34(5):44-47. 被引量：1
-
2张生梅,贺小桔,李丁丁,陈婉秋,张彦亮.代谢相关脂肪性肝病和肌少症的相关研究进展[J].巴楚医学,2022,5(4):97-100.
-
3张伟,卢秉久,张艳.聚焦外泌体探讨代谢相关脂肪性肝病患者冠脉血管损伤的科学内涵[J].中医学报,2023,38(8):1614-1620.
-
4孙天琪,卢秉久.MS-1A型脂肪肝治疗仪治疗代谢相关脂肪性肝病的临床观察[J].锦州医科大学学报,2023,44(6):37-42.
-
5李岩,颜学兵,陆忠华,季芳.非酒精性脂肪性肝病更名前后的人群分布变化及代谢功能障碍相关脂肪性肝病肝纤维化的危险因素分析[J].临床肝胆病杂志,2024,40(6):1136-1141.
-
6孙天琪,卢秉久,郑佳连.二陈汤加减联合多烯磷脂酰胆碱胶囊治疗代谢相关脂肪性肝病临床观察[J].河北中医,2024,46(6):936-940.
-
7夏雪碧露,高鹏飞,胡春兰,姚绮霞.非酒精性脂肪性肝病从脾虚论治的研究进展[J].临床医学进展,2023,13(3):4270-4278.
-
1Modou Badiane,Prince Abdoul Aziz Honadia,Bernard Zouma,Fabé Idrissa Barro.Quadratic Boost Converter: An Analysis with Passive Components Losses[J].Open Journal of Applied Sciences,2021,11(2):202-215.
-
2Hong-Xin Wang,Michael J.Moore,Russell L.Barrett,Sven Landrein,Shota Sakaguchi,Masayuki Maki,Jun Wen,Hua-Feng Wang.Plastome phylogenomic insights into the Sino-Japanese biogeography of Diabelia(Caprifoliaceae)[J].Journal of Systematics and Evolution,2020,58(6):972-987. 被引量：5
